Ideas in this flowchart

• CRISPR-based identification of synthetic lethal interactions advances targeted cancer therapy
• Researchers developed a CRISPR screening platform to identify synthetic lethal interactions
• Synthetic lethality occurs when two otherwise tolerated gene changes occur simultaneously and cause cell death
• The platform evaluates interactions across multiple cancer types
• The screening results were paired with large-scale drug sensitivity data from tumor cell line screens
• Large-scale drug sensitivity data from tumor cell line screens
• The combined analysis identified gene alterations that sensitize cancer cells to specific drugs
• This approach can systematically match cancer patients with targeted therapies
• The findings advance synthetic lethality-based treatment strategies
• Fong SH et al. (2025), Nature Genetics 57